1 min read|28 words
Plasma histidine: one amino acid, five cancer types, one powerful survival signal. Metabolomic profiling is reshaping how we predict immunotherapy response.
Read the full article on GMJ Newsroom →
Was this article helpful?
Key Finding: Plasma histidine levels linked to immunotherapy survival: a metabolomic breakthrough
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
